DDX5 and hepatocellular carcinoma: Our goal is to provide a unifying interpretation to the observations from PDAC and/or HCC in some publications reviewed recently [41] that are inconsistent with others for DDX5 to act as a cancer biomarker and target by using the gradually established DDX5’s DNA repair function.